Debt financing for Occlutech Holding AG (CH) – EUR 40 million

Carnegie acted as financial adviser to Occlutech when obtaining subscription commitment of bonds. Occlutech receives subscription commitment of bonds amounting to EUR 40 million in nominal value under a total frame of EUR 75 million to finance US expansion and growth. Occlutech is a leading specialist provider of minimally invasive structural heart implants, with a mission to improve the quality of life for people with heart conditions. The vision is to become a leading global specialist in cardiac implants, addressing congenital heart defects, stroke prevention and heart failure.